Post by
1998novl on Oct 16, 2020 8:08pm
Overreaction
I think many here would make great executives and would do great investor relations work. Unfortunately as a shareholder, you've allocated that responsibility to the company. You can vote your shares and even become an activist if you have enough shares. As a shareholder you are not entitled to the whole story, in fact you are only entitled to public information. If you get non public information you are locked out from trading the stock. As much as I would like a prefect message from the company, I would prefer them to execute in getting another drug approved with the FDA, which they have been successful at before. So either trust them and keep your shares or don't and sell them - but to bombard them for not being perfect in answering questions around non public information isn't fair. They have improved communication extremely well since the end of last year and are allocating resources to improving in that arena, that part is clear to me. Also, today's addition of the Molson family is likely the largest endorsement in credibility one could ask for, but I'm sure it's not good enough to those on this board that are short term focused on next weeks share price..., patience folks!!
Comment by
1998novl on Oct 16, 2020 8:56pm
The discussions they have had with FDA and EMA are material NON public information. Can you see how they are in a difficult position and cannot be fully transparent?
Comment by
realitycheck4u on Oct 16, 2020 10:15pm
This post has been removed in accordance with Community Policy
Comment by
houbahop on Oct 17, 2020 8:11am
..."That is a harsh lesson that I hope they understand and we should ask if they do and what their plan is that will be different going forward." It has been like this for over 20 years. What make you think it will change in the future? They do not need to be thought any lesson. They do it this way to serve some personal interests.
Comment by
realitycheck4u on Oct 17, 2020 8:39am
This post has been removed in accordance with Community Policy
Comment by
Bucknelly21 on Oct 17, 2020 10:53am
It's funny scarlet so I can only think that the one thing all these issues have in common is that everyone points to upper management. Question is how who has been at thrx the longest that would have a say in communication issues? Is it the board? Is it Phillipe? One would think that when you can pin point that person you will find the problem
Comment by
Sqidmandon on Oct 18, 2020 9:41am
Trust me, they are all getting an email from me
Comment by
scarlet1967 on Oct 17, 2020 12:50pm
I want to know why a mega pharma like Takeda pays 470 million dollars plus loyalties and funds to cover R&D expenses for a private company's preclinical NASH protocol yet THTX gets no added value for their 3 upcoming programs???
Comment by
Sqidmandon on Oct 18, 2020 9:44am
Not the point...doing the right things for the business include not only the internal management of the company and product, but external management of communication...they are not mutually exclusive
Comment by
1998novl on Oct 18, 2020 11:44am
I imagine you would not be satisfied owning shares of Berkshire Hathaway and getting communication once per year and nothing else.
Comment by
realitycheck4u on Oct 18, 2020 12:35pm
This post has been removed in accordance with Community Policy